NO20056135L - Karboksylforbindelse og medisin som omfatter denne - Google Patents

Karboksylforbindelse og medisin som omfatter denne

Info

Publication number
NO20056135L
NO20056135L NO20056135A NO20056135A NO20056135L NO 20056135 L NO20056135 L NO 20056135L NO 20056135 A NO20056135 A NO 20056135A NO 20056135 A NO20056135 A NO 20056135A NO 20056135 L NO20056135 L NO 20056135L
Authority
NO
Norway
Prior art keywords
medicine
diabetes
integer
carboxyl compound
hyperlipemia
Prior art date
Application number
NO20056135A
Other languages
English (en)
Inventor
Takahiro Kitamura
Yukiyoshi Yamazaki
Keisuke Inoue
Tsutomu Toma
Tetsuya Ishikawa
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO20056135L publication Critical patent/NO20056135L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Sammendrag Forbindelse som er representert ved den følgende generelle formel (1), et salt derav eller en ester derav: der m representerer et helt tall fra 0 til 4, n representerer et helt tall fra 5 til 9 og W representerer -CH(OR)- (der R representerer hydrogenatom eller en beskyttende gruppe av hydroksylgruppe) eller -C(=O)-, som har reduserende virkning på blodglukose, plasmainsulin og triglyserid, og som er nyttig for preventiv og/eller terapeutisk behandling av diabetes, komplikasjoner ved diabetes, hyperlipemi og andre.
NO20056135A 2003-05-23 2005-12-22 Karboksylforbindelse og medisin som omfatter denne NO20056135L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47273703P 2003-05-23 2003-05-23
JP2003154372 2003-05-30
PCT/JP2004/007316 WO2004103946A1 (ja) 2003-05-23 2004-05-21 カルボン酸化合物及びこれを含有する医薬

Publications (1)

Publication Number Publication Date
NO20056135L true NO20056135L (no) 2005-12-22

Family

ID=33479004

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056135A NO20056135L (no) 2003-05-23 2005-12-22 Karboksylforbindelse og medisin som omfatter denne

Country Status (14)

Country Link
EP (1) EP1627866B1 (no)
KR (1) KR20060031605A (no)
AT (1) ATE418532T1 (no)
AU (1) AU2004241224A1 (no)
BR (1) BRPI0411136A (no)
CA (1) CA2526637A1 (no)
DE (1) DE602004018634D1 (no)
EA (1) EA010020B1 (no)
IL (1) IL171993A0 (no)
MX (1) MXPA05012612A (no)
MY (1) MY132415A (no)
NO (1) NO20056135L (no)
NZ (1) NZ544155A (no)
WO (1) WO2004103946A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1752145A1 (en) * 2004-06-01 2007-02-14 Kowa Company Ltd. Therapeutic agent for hyperlipemia and therapeutic agent for diabetes
WO2006118187A1 (ja) * 2005-04-28 2006-11-09 Ube Industries, Ltd. ２，２－ジクロロ－１２－（４－ハロフェニル）ドデカン酸塩及びその製造中間体の製法
JPWO2007114223A1 (ja) 2006-03-31 2009-08-13 興和株式会社 カルボン酸化合物の製造方法
WO2009038204A1 (ja) * 2007-09-17 2009-03-26 Pharma Frontier Co., Ltd. 新規長鎖脂肪酸誘導体化合物及びそれら化合物を有効成分とするｇタンパク質共役型レセプター作動剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CN1259909C (zh) * 2002-01-16 2006-06-21 兴和株式会社 含有2,2－二氯－12－(4－氯苯基)－十二烷酸的药物组合物

Also Published As

Publication number Publication date
NZ544155A (en) 2008-03-28
EP1627866A4 (en) 2006-10-04
EA200501853A1 (ru) 2006-06-30
DE602004018634D1 (de) 2009-02-05
IL171993A0 (en) 2009-02-11
MXPA05012612A (es) 2006-02-22
EP1627866B1 (en) 2008-12-24
MY132415A (en) 2007-10-31
BRPI0411136A (pt) 2006-07-18
WO2004103946A1 (ja) 2004-12-02
EP1627866A1 (en) 2006-02-22
EA010020B1 (ru) 2008-06-30
ATE418532T1 (de) 2009-01-15
AU2004241224A1 (en) 2004-12-02
CA2526637A1 (en) 2004-12-02
KR20060031605A (ko) 2006-04-12

Similar Documents

Publication Publication Date Title
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
EP1980560A3 (en) C-glycoside derivatives for the treatment of diabetes
CA2474578A1 (en) Novel pyridin- and pyrimidin-derivatives
DE602005013822D1 (de) Cycloalkylaminderivate
AU4396899A (en) Remedies for diabetes
NO20056135L (no) Karboksylforbindelse og medisin som omfatter denne
HK1054373A1 (en) Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
EP1147772A4 (en) DRUG COMPOSITIONS FOR THE TREATMENT OF EAR FIBRILLATION
TW200740786A (en) Novel cercosporamide derivatives
TW200503681A (en) Carboxylic compound and medicine comprising the same
DE60013560D1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
HUP0303353A2 (hu) Profilaktikus és terápiás szer diabeteses komplikációkhoz
EP1726587A4 (en) BENZOTHIAZINE-3-ONE COMPOUND AND INTERMEDIATE PRODUCTS THEREOF
EP1666472A4 (en) PHENYL ACETIC ACID DERIVATIVE, METHOD FOR THE PRODUCTION AND USE THEREOF
AU2001260695A1 (en) Malto-oligosaccharide derivatives and use thereof
SI1493441T1 (sl) Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano
TH71668A (th) สารประกอบคาร์บอกซิลิก และสารที่ใช้รักษาโรคซึ่งประกอบด้วยสารประกอบนี้
MXPA05008190A (es) Derivado de oligosacarido.
EP1484316A4 (en) NEW PROPIONIC ACID DERIVATIVE
NO20042881L (no) Substituerte cykloheksan-derivater
TW200503714A (en) Pde9 inhibitors for treating type 2 diabetes, metabolic syndrome, and cardiovascular disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application